Bill Radke speaks with Luke Timmerman about what went wrong during Seattle-based Juno Therapeutics' clinical trial of an immunotherapy treatment for leukemia and what it might mean for the company.
Bill Radke speaks with Luke Timmerman about what went wrong during Seattle-based Juno Therapeutics' clinical trial of an immunotherapy treatment for leukemia and what it might mean for the company.